Symposium / September 22, 2026 - September 23, 2026
3rd Fraunhofer CIMD Symposium on RNA-Based Therapeutics
Explore the full potential of RNA technologies - from breakthrough research to real-world clinical applications!
RNA technologies hold vast therapeutic potential, offering innovative strategies for the precise treatment of diseases such as cancer and viral infections, while also enabling the development of personalized therapies.
This year’s symposium explores the immense promise of RNA molecules as next-generation therapeutics – extending far beyond the success of mRNA vaccines. RNA-based approaches, particularly antisense oligonucleotides (ASOs), are already making their impact in clinical applications.
Topics and highlights
Dive into the latest advancements and gain insights! Through a keynote lecture, invited expert talks and poster presentations, participants will gain insights into current developments in
- RNA biology and translation
- Industry perspectives on RNA innovation
- RNA manufacturing, formulation, and delivery
- Enabling platforms for RNA medicines
- Fraunhofer innovations shaping RNA therapeutics
Why attend?
From foundational RNA biology to advanced delivery systems, this symposium addresses key topics in next-generation therapeutics.
- Discover emerging technologies and real-world applications shaping the future of therapeutics.
- Gain insights that bridge the gap between research and real-world impact.
- Present your work, engage in discussions, and build your network with fellow experts.
Join our symposium in September 2026! We look forward to welcoming you and to exploring the present and future of RNA therapeutics with you!
Are you interested in sponsorship or exhibition opportunities? We offer attractive sponsorship and exhibition options for the symposium. More information is available here.
Fraunhofer Institute for Toxicology and Experimental Medicine